Sherwin Kb Sy

22PUBLICATIONS

24CO-AUTHORS

Gene and molecular therapyPredictive and prognostic markersMedical biochemistry - proteins and peptides (incl. medical proteomics)Medical bacteriologyHaematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (22)

Sort by Publication Date:

|Jul 03, 2026

FDA Gene Therapy Approvals (1998-2025): Current Status, Regulatory Evolution, and Future Directions.

|Feb 11, 2026

Leveraging Model-Informed Drug Development to Predict Asciminib Efficacy in Second-Line Treatment of Chronic Myeloid Leukemia in Chronic Phase.

Sherwin K B Sy, Deok Yong Yoon, Yiqun Yang

|Jul 30, 2025

The Application of Quantitative <sup>1</sup>H-NMR for the Determination of Melatonin and Vitamin B6 in Commercial Melatonin Products.

Xinyu Gao, Jiahao Niu, Zhengjian Xiao

|Feb 11, 2025

The impact of aztreonam-clavulanic acid exposure on gene expression and mutant selection using a multidrug-resistant <i>E. coli</i>.

Tongtong Lin, Jiayuan Zhang, Shuo Diao

|Dec 31, 2024

Population modelling of nilotinib exposure vs. longitudinal BCR::ABL1 response in patients with chronic phase chronic myeloid leukaemia using a semimechanistic disease model.

Sherwin K B Sy, Deok Yong Yoon, Christelle Darstein

|Oct 29, 2024

Clinical Pharmacology of Asciminib: A Review.

Matthias Hoch, Felix Huth, Paul William Manley

Pageof 4

Frequent Collaborators

4 joint publications

Francois Pierre Combes

4 joint publications

Mingming Yu

3 joint publications

Ying Fei Li

2 joint publications

Frederico Severino Martins

Yan Ji

Carla Biesdorf

Andrea Diniz

Xinhui Chen

José Eduardo Severino Martins

1 joint publications

Patricia Severino

Frequent Collaborators

4 joint publications

Francois Pierre Combes

4 joint publications

Mingming Yu

3 joint publications

Ying Fei Li

2 joint publications

Frederico Severino Martins